MedKoo Cat#: 578647 | Name: Sisomicin sulfate
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Sisomicin (bactoCeaze, ensamycin, and initially antibiotic 6640 and rickamicin), is an aminoglycoside antibiotic, isolated from the fermentation broth of Micromonospora inositola. It is a newer broad-spectrum aminoglycoside most structurally related to gentamicin. Some studies show that sisomicin has been effective in the treatment of infections that either had failed to respond to other drugs or were due to microorganisms resistant in vitro to other aminoglycosides.

Chemical Structure

Sisomicin sulfate
Sisomicin sulfate
CAS#53179-09-2 (sulfate)

Theoretical Analysis

MedKoo Cat#: 578647

Name: Sisomicin sulfate

CAS#: 53179-09-2 (sulfate)

Chemical Formula: C38H84N10O34S5

Exact Mass: 1384.3755

Molecular Weight: 1385.43

Elemental Analysis: C, 32.94; H, 6.11; N, 10.11; O, 39.26; S, 11.57

Price and Availability

Size Price Availability Quantity
500mg USD 450.00 2 Weeks
1g USD 750.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Synonym
Antibiotic 66-40 sulfate; Baymicine; Extramycin; Pathomycin; Sisomicin sulfate
IUPAC/Chemical Name
bis((2R,3R,4R,5R)-2-(((1S,2S,3R,4S,6R)-4,6-diamino-3-(((2S,3R)-3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-hydroxycyclohexyl)oxy)-5-methyl-4-(methylamino)tetrahydro-2H-pyran-3,5-diol) pentakis(sulfate)
InChi Key
CIKNYWFPGZCHDL-ZHFUJENKSA-N
InChi Code
InChI=1S/2C19H37N5O7.5H2O4S/c2*1-19(27)7-28-18(13(26)16(19)24-2)31-15-11(23)5-10(22)14(12(15)25)30-17-9(21)4-3-8(6-20)29-17;5*1-5(2,3)4/h2*3,9-18,24-27H,4-7,20-23H2,1-2H3;5*(H2,1,2,3,4)/t2*9-,10+,11-,12+,13-,14-,15+,16-,17-,18-,19+;;;;;/m11...../s1
SMILES Code
CN[C@@H]1[C@@H](O)[C@@H](O[C@H]2[C@H](N)C[C@H](N)[C@@H](O[C@H]3OC(=CC[C@H]3N)CN)[C@@H]2O)OC[C@]1(C)O.CN[C@@H]4[C@@H](O)[C@@H](O[C@H]5[C@H](N)C[C@H](N)[C@@H](O[C@H]6OC(=CC[C@H]6N)CN)[C@@H]5O)OC[C@]4(C)O.OS(=O)(=O)O.OS(=O)(=O)O.OS(=O)(=O)O.OS(=O)(=O)O.OS(=O)(=O)O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 1,385.43 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Guan S, Li Y, Cheng C, Gao X, Gu X, Han X, Ye H. Manufacture of pH- and HAase-responsive hydrogels with on-demand and continuous antibacterial activity for full-thickness wound healing. Int J Biol Macromol. 2020 Dec 1;164:2418-2431. doi: 10.1016/j.ijbiomac.2020.08.108. Epub 2020 Aug 13. PMID: 32798544. 2: Yuan C, Wang J, Liang Z, Xin N. [Determination of sisomicin in body fluid by high performance liquid chromatography-indirect photometric detection method]. Se Pu. 1998 Sep;16(5):445-7. Chinese. PMID: 11498926. 3: Matsukawa S, Suh JH, Hashimoto Y, Kato M, Satoh D, Saito S, Endo K, Saishu T. Neuromuscular blocking actions of the aminoglycoside antibiotics sisomicin and micronomicin in the rabbit. Tohoku J Exp Med. 1997 Apr;181(4):471-3. doi: 10.1620/tjem.181.471. PMID: 9210254. 4: Fukuda M, Sasaki K. Changes in the antibacterial activity of melanin-bound drugs. Ophthalmic Res. 1990;22(2):123-7. doi: 10.1159/000267011. PMID: 2111531. 5: Tamura K, Araki Y, Amamoto T, Seita M. [Clinical experience of sisomicin sulfate by intravenous drip infusion for the treatment of infection complicated by malignant disease]. Jpn J Antibiot. 1984 Jul;37(7):1237-40. Japanese. PMID: 6593472. 6: Egorenko GG, Berezina EK, Berezhinskaia VV, Dolgova GV, Kovalenko LP. IZuchenie obshchetoksicheskikh i organotropnykh svoĭstv sizomitsina sul'fata v khronicheskikh opytakh na zhivotnykh [General toxic and organotropic properties of sisomicin sulfate in chronic experiments on animals]. Antibiotiki. 1983 Sep;28(9):678-82. Russian. PMID: 6605712. 7: Matsuzawa T, Nakata M, Tsushima M, Miura H, Akiyoshi M. Audiotoxicosis in newborn guinea pigs from pregnant ones given sisomicin. Toxicology. 1980;17(1):67-71. doi: 10.1016/0300-483x(80)90028-1. PMID: 7434369. 8: Rodríquez Torres A. Sulfato de sisomicina: su eficacia en el tratamiento de las infecciones urológicas [Sisomicin sulfate: its efficacy in the treatment of urologic infections]. Arch Esp Urol. 1979 Jul-Aug;32(4):387-96. Spanish. PMID: 485572. 9: Varela Rico J, Monroy López J, Núñez Díaz A, Ortega González M. Nuevo aminoglucosido en infecciones del aparato urogenital. Estudio clínico del sulfato de sisomicina [A new aminoglucoside in infections of the urogenital system. Clinical study of sisomicin sulfate]. Prensa Med Mex. 1978 Jul- Aug;43(7-8):258-60. Spanish. PMID: 392493.